CELC - Celcuity Inc.
IEX Last Trade
10.85
0.085 0.783%
Share volume: 428,363
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$10.76
-1.07
-0.09%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-15 | 2023-08-11 | 2023-11-13 | 2024-11-14 | 2024-05-15 | 2024-08-14 | 2024-11-14 | |
| Assets | ||||||||
| Total Assets | 164.875 M | 153.517 M | 142.384 M | 191.219 M | 188.181 M | 292.545 M | 273.037 M | |
| Current Assets | 164.100 M | 152.806 M | 141.711 M | 190.591 M | 187.523 M | 291.931 M | 272.438 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 57.606 K | 101.097 K | 0.000 | 10.008 M | 9.861 M | 8.863 M | 8.380 M | |
| Short Term Investments | 123.839 M | 114.005 M | 108.180 M | 149.920 M | 146.448 M | 252.610 M | 251.455 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 33.639 M | 32.239 M | 25.760 M | 30.663 M | 31.215 M | 30.459 M | 12.603 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 223.343 K | 210.858 K | 223.378 K | 228.782 K | 306.024 K | 308.444 K | 338.787 K | |
| Other Assets | 551.933 K | 499.993 K | 449.368 K | 400.019 K | 351.911 K | 305.179 K | 259.744 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 164.875 M | 153.517 M | 142.384 M | 191.219 M | 188.181 M | 292.545 M | 273.037 M | |
| Total liabilities | 41.648 M | 43.385 M | 49.488 M | 51.450 M | 54.444 M | 115.860 M | 123.328 M | |
| Total current liabilities | 5.806 M | 7.082 M | 12.710 M | 14.189 M | 16.696 M | 19.528 M | 26.309 M | |
| Accounts Payable | 2.570 M | 3.019 M | 5.635 M | 5.077 M | 5.277 M | 6.203 M | 9.159 M | |
| Other liabilities | 363.961 K | 317.120 K | 270.925 K | 225.922 K | 182.079 K | 138.533 K | 95.699 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 35.478 M | 35.986 M | 36.507 M | 37.035 M | 37.566 M | 96.193 M | 96.924 M | |
| Other liabilities | 363.961 K | 317.120 K | 270.925 K | 225.922 K | 182.079 K | 138.533 K | 95.699 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 123.226 M | 110.131 M | 92.895 M | 139.768 M | 133.736 M | 176.684 M | 149.708 M | |
| Common stock | 231.461 M | 232.954 M | 234.123 M | 299.844 M | 315.425 M | 382.095 M | 384.910 M | |
| Retained earnings | -108.235 M | -122.823 M | -141.228 M | -160.076 M | -181.688 M | -205.410 M | -235.202 M |